%0 Journal Article
%T Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases.
%A Alonzi T
%A Aiello A
%A Sali M
%A Delogu G
%A Villella VR
%A Raia V
%A Nicastri E
%A Piacentini M
%A Goletti D
%J Biomed Pharmacother
%V 178
%N 0
%D 2024 Sep 17
%M 39024833
%F 7.419
%R 10.1016/j.biopha.2024.117153
%X Infectious diseases are a major threat to global health and cause millions of deaths every year, particularly in developing countries. The emergence of multidrug resistance challenges current antimicrobial treatments, inducing uncertainty in therapeutic protocols. New compounds are therefore necessary. A drug repurposing approach could play a critical role in developing new treatments used either alone or in combination with standard therapy regimens. Herein, we focused on cysteamine, an aminothiol endogenously synthesized by human cells during the degradation of coenzyme-A, which is a drug approved for the treatment of nephropathic cystinosis. Cysteamine influences many biological processes due to the presence of the highly reactive thiol group. This review provides an overview of cysteamine-mediated effects on different viruses, bacteria and parasites, with a particular focus on infections caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Mycobacterium tuberculosis, non-tuberculous mycobacteria (NTM), and Pseudomonas aeruginosa. Evidences for a potential use of cysteamine as a direct antimicrobial agent and/or a host-directed therapy, either alone or in combination with other antimicrobial drugs, are described.